{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Neuroinflammatory+Disorders&page=16", "query": { "condition": "Neuroinflammatory Disorders", "page": 16 }, "page_size": 10 }, "pagination": { "page": 16, "page_size": 10, "total_count": 399, "total_pages": 40, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Neuroinflammatory+Disorders&page=17&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Neuroinflammatory+Disorders&page=15&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-18T00:13:00.198Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01108549", "title": "Treatment of Chronic Fatigue Syndrome and Fibromyalgia With D-ribose- a Multicenter Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Fibromyalgia", "Chronic Fatigue Syndrome" ], "interventions": [ { "name": "Ribose", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Kona Research Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 257, "start_date": "2009-04", "completion_date": "2009-09", "has_results": false, "last_update_posted_date": "2010-04-22", "last_synced_at": "2026-10-18T00:13:00.198Z", "location_count": 1, "location_summary": "Green Bay, Wisconsin", "locations": [ { "city": "Green Bay", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01108549" }, { "nct_id": "NCT02500511", "title": "Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Meningococcal Meningitis", "Meningococcal Infections" ], "interventions": [ { "name": "NmVac4-A/C/Y/W-135-DT™", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "JN-International Medical Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 50, "start_date": "2015-06", "completion_date": "2015-09", "has_results": false, "last_update_posted_date": "2016-04-12", "last_synced_at": "2026-10-18T00:13:00.198Z", "location_count": 1, "location_summary": "Towson, Maryland", "locations": [ { "city": "Towson", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02500511" }, { "nct_id": "NCT05129514", "title": "Imaging Lymphatic/Cerebrospinal Fluid (CSF) Drainage From the Head and Neck in Persons With Traumatic Brain Injury: Demonstration of Feasibility and Evaluation of Manual Therapy to Improve Drainage and Facilitate Cognitive Recovery", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Trauma, Brain", "Neuroinflammation" ], "interventions": [ { "name": "Manual Lymphatic Drainage (MLD)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2022-05-18", "completion_date": "2023-12-31", "has_results": false, "last_update_posted_date": "2026-03-10", "last_synced_at": "2026-10-18T00:13:00.198Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05129514" }, { "nct_id": "NCT02096263", "title": "Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Poliomyelitis", "Diphtheria", "Haemophilus Influenzae Type b", "Tetanus", "Acellular Pertussis", "Hepatitis B" ], "interventions": [ { "name": "Infanrix hexa", "type": "BIOLOGICAL" }, { "name": "Pediarix", "type": "BIOLOGICAL" }, { "name": "ActHIB", "type": "BIOLOGICAL" }, { "name": "Pentacel", "type": "BIOLOGICAL" }, { "name": "Engerix-B", "type": "BIOLOGICAL" }, { "name": "Infanrix", "type": "BIOLOGICAL" }, { "name": "Hiberix", "type": "BIOLOGICAL" }, { "name": "Prevnar13", "type": "BIOLOGICAL" }, { "name": "Rotarix", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 585, "start_date": "2014-04-16", "completion_date": "2015-11-13", "has_results": true, "last_update_posted_date": "2019-11-27", "last_synced_at": "2026-10-18T00:13:00.198Z", "location_count": 43, "location_summary": "Tucson, Arizona • Fayetteville, Arkansas • Anaheim, California + 38 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Daly City", "state": "California" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02096263" }, { "nct_id": "NCT00071162", "title": "Genetics of Fibromyalgia", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Fibromyalgia", "Irritable Bowel Syndrome", "Chronic Fatigue Syndrome", "Depression" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 560, "start_date": "1999-09", "completion_date": null, "has_results": false, "last_update_posted_date": "2009-04-01", "last_synced_at": "2026-10-18T00:13:00.198Z", "location_count": 4, "location_summary": "Peoria, Illinois • Cincinnati, Ohio • Cleveland, Ohio + 1 more", "locations": [ { "city": "Peoria", "state": "Illinois" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00071162" }, { "nct_id": "NCT00074607", "title": "Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Meningitis", "Neoplasms" ], "interventions": [ { "name": "Gemcitabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": null, "sex": "ALL", "summary": "3 Years and older" }, "enrollment_count": 10, "start_date": "2001-12", "completion_date": "2007-04", "has_results": false, "last_update_posted_date": "2012-11-12", "last_synced_at": "2026-10-18T00:13:00.198Z", "location_count": 5, "location_summary": "Bethesda, Maryland • Pittsburgh, Pennsylvania • Houston, Texas + 1 more", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Houston", "state": "Texas" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00074607" }, { "nct_id": "NCT03100136", "title": "Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET Tacer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neuroinflammation" ], "interventions": [ { "name": "[11C]PF-06809247", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 7, "start_date": "2016-11-16", "completion_date": "2017-03-10", "has_results": false, "last_update_posted_date": "2017-04-04", "last_synced_at": "2026-10-18T00:13:00.198Z", "location_count": 3, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03100136" }, { "nct_id": "NCT04094818", "title": "TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Respiratory Tract Infections", "Urinary Tract Infections", "Intra-Abdominal Infections", "Skin and Soft Tissue Infection", "Suspected Meningitis/Encephalitis or Any Other Infection", "Sepsis" ], "interventions": [ { "name": "TriVerity", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Inflammatix", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1441, "start_date": "2020-02-28", "completion_date": "2024-09-30", "has_results": false, "last_update_posted_date": "2024-10-22", "last_synced_at": "2026-10-18T00:13:00.198Z", "location_count": 25, "location_summary": "Mobile, Alabama • Los Angeles, California • Sacramento, California + 22 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04094818" }, { "nct_id": "NCT07551999", "title": "A Study Of Remote Voice Analysis Tool For Diagnosing And Monitoring ME/CFS", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Encephalomyelitis", "Chronic Fatigue Syndrome" ], "interventions": [ { "name": "Voice Recording", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2026-05-26", "completion_date": "2028-07", "has_results": false, "last_update_posted_date": "2026-05-27", "last_synced_at": "2026-10-18T00:13:00.198Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT07551999" }, { "nct_id": "NCT00746798", "title": "Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "West Nile Fever" ], "interventions": [ { "name": "ChimeriVax-WN02 vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 479, "start_date": "2008-10", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2015-04-03", "last_synced_at": "2026-10-18T00:13:00.198Z", "location_count": 15, "location_summary": "Anaheim, California • Colorado Springs, Colorado • South Miami, Florida + 12 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "South Miami", "state": "Florida" }, { "city": "Boise", "state": "Idaho" }, { "city": "Idaho Falls", "state": "Idaho" } ], "official_url": "https://clinicaltrials.gov/study/NCT00746798" } ] }